Aurinia Pharmaceuticals Inc. (AUPH) Balance Sheet
As of 2026-06-30 (10-Q), Aurinia Pharmaceuticals Inc. (AUPH) reported total assets of $792.3M, total liabilities of $177.4M and shareholders' equity of $614.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $179.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AUPHAurinia Pharmaceuticals Inc.Follow AUPH — free
—
Price chart with a free account
- Market cap
- 2.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | 165.6 | 118.0 | 306.0 | 272.4 | 231.9 | 94.1 | 48.8 | 83.4 | 80.2 | 179.7 | |
| Short-term investments | — | — | — | 0.0 | 126.0 | 234.2 | 295.2 | 301.6 | 275.0 | 317.8 | 263.3 | |
| Receivables | — | — | — | 0.4 | 0.0 | 15.4 | 13.5 | 24.1 | 36.5 | 41.5 | 41.1 | |
| Inventory | — | — | — | 0.0 | 13.9 | 19.3 | 24.8 | 39.7 | 39.2 | 45.7 | 45.2 | |
| Current assets | 41.4 | 175.3 | 132.8 | 315.1 | 419.4 | 513.3 | 442.5 | 424.8 | 446.6 | 492.0 | 541.3 | |
| Total assets | 57.0 | 189.8 | 145.9 | 324.3 | 463.7 | 543.4 | 470.9 | 548.1 | 550.6 | 751.6 | 792.3 | |
| Current liabilities | 7.9 | 8.2 | 7.3 | 11.3 | 32.0 | 40.6 | 46.1 | 77.2 | 97.8 | 93.7 | 99.9 | |
| Total liabilities | 21.0 | 24.1 | 33.3 | 25.7 | 55.9 | 64.3 | 65.4 | 170.1 | 173.2 | 170.3 | 177.4 | |
| Shareholders' equity | 36.0 | 177.9 | 135.7 | 298.6 | 407.8 | 479.1 | 405.4 | 378.0 | 377.5 | 581.3 | 614.9 |
USD millions · SEC XBRL
Aurinia Pharmaceuticals Inc. — questions
- How much cash does Aurinia Pharmaceuticals Inc. have?
- $179.7M in cash and cash equivalents as of 2026-06-30.
- What are Aurinia Pharmaceuticals Inc.'s total assets?
- $792.3M as of 2026-06-30.
- What is Aurinia Pharmaceuticals Inc.'s shareholders' equity?
- $614.9M as of 2026-06-30.
Every figure on this page comes from Aurinia Pharmaceuticals Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.